Novartis
NVS
NVS
1,222 hedge funds and large institutions have $15.1B invested in Novartis in 2023 Q3 according to their latest regulatory filings, with 96 funds opening new positions, 374 increasing their positions, 448 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.01% more ownership
Funds ownership: 6.52% → 6.52% (+0.01%)
6% less call options, than puts
Call options by funds: $253M | Put options by funds: $270M
17% less repeat investments, than reductions
Existing positions increased: 374 | Existing positions reduced: 448
Holders
1,222
Holding in Top 10
16
Calls
$253M
Puts
$270M
Top Buyers
| 1 | +$117M | |
| 2 | +$70M | |
| 3 | +$55.5M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$47.9M |
| 5 |
Renaissance Technologies
New York
|
+$28.7M |
Top Sellers
| 1 | -$73.9M | |
| 2 | -$42.3M | |
| 3 | -$41.5M | |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$31.3M |
| 5 |
Morgan Stanley
New York
|
-$29.3M |